New variants expand the neurological phenotype of COQ7 deficiency
Journal of Inherited Metabolic Disease · 2024
DOI: 10.1002/jimd.12776 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Inherited Metabolic Disease, 2024. Verfasst von María Alcázar Fabra und 33 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiología, Anatomía y Biología Celular, CABD, Universidad Pablo de Olavide, Sevilla, Spain. Hauptthemen laut MEDLINE: Ubiquinone, Fibroblasts, Phenotype, Mutation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Instituto de Salud Carlos III, Junta de Andalucía, Ministerio de Educación, Cultura y Deporte.
Abstract (Originalsprache)
The protein encoded by COQ7 is required for CoQ 10 synthesis in humans, hydroxylating 3‐demethoxyubiquinol (DMQ 10 ) in the second to last steps of the pathway. COQ7 mutations lead to a primary CoQ 10 deficiency syndrome associated with a pleiotropic neurological disorder. This study shows the clinical, physiological, and molecular characterization of four new cases of CoQ 10 primary deficiency caused by five mutations in COQ7 , three of which have not yet been described, inducing mitochondrial dysfunction in all patients. However, the specific combination of the identified variants in each patient generated precise pathophysiological and molecular alterations in fibroblasts, which would explain the differential in vitro response to supplementation therapy. Our results suggest that COQ7 dysfunction could be caused by specific structural changes that affect the interaction with COQ9 required for the DMQ 10 presentation to COQ7, the substrate access to the active site, and the maintenance of the active site structure. Remarkably, patients' fibroblasts share transcriptional remodeling, supporting a modification of energy metabolism towards glycolysis, which could be an adaptive mechanism against CoQ 10 deficiency. However, transcriptional analysis of mitochondria‐associated pathways showed distinct and dramatic differences between patient fibroblasts, which correlated with the extent of pathophysiological and neurological alterations observed in the probands. Overall, this study suggests that the combination of precise genetic diagnostics and the availability of new structural models of human proteins could help explain the origin of phenotypic pleiotropy observed in some genetic diseases and the different responses to available therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Fisiología, Anatomía y Biología Celular, CABD, Universidad Pablo de Olavide, Sevilla, Spain.
- Unidad U729 CIBERER, Instituto de Salud Carlos III, Sevilla, Spain.
- Hospital San Joan de Deu, Barcelona, Spain.
- Unidad U703 CIBERER, Instituto de Salud Carlos III, Barcelona, Spain.
- Unidad de Diagnóstico y Tratamiento de Enfermedades Metabólicas Congénitas, Hospital de Santiago de Compostela, IDIS, CIBERER, MetabERN, Santiago de Compostela, Spain.
- GCV14/ER/5 CIBERER, Instituto de Salud Carlos III, Santiago de Compostela, Spain.
ORCID-Profile: María Alcázar Fabra, Abraham J Paredes-Fuentes, Manuel Torralba Carnerero, Daniel J Moreno Férnandez de Ayala, Antonio Arroyo Luque, Ana Sánchez Cuesta, Carmine Staiano, Paula Sanchez-Pintos, María Luz Couce, Miguel Tomás, Ana Victoria Marco-Hernández, Carmen Orellana, Mónica Roselló, Alfonso Caro, Juan Silvestre Oltra Soler, Sandra Monfort, Dolores Rausell, Isidro Vitoria, Mireia Del Toro, Angels Garcia-Cazorla, Cristina Jou, Delia Yubero, Juan Diego Hernández Camacho, Guillermo López Lluch, Manuel Ballesteros Simarro, Juan Carlos Rodríguez Aguilera, Gloria Brea Calvo, María Victoria Cascajo Almenara, Rafael Artuch, Carlos Santos-Ocaña
Förderung
- Instituto de Salud Carlos III
- Junta de Andalucía
- Ministerio de Educación, Cultura y Deporte
- Departament de Salut, Generalitat de Catalunya
- Muscular Dystrophy Association
- E-Rare Programme 2023 and the European Joint Programmes on Rare Diseases (EJP RD) GENOMIT-4
- Ministry of Education, Culture and Sports
Zitieren
APA
Fabra, M. A., Paredes-Fuentes, A. J., Torralba Carnerero, M., Moreno Férnandez de Ayala, D. J., Arroyo Luque, A., Sánchez Cuesta, A., Staiano, C., Sanchez-Pintos, P., Luz Couce, M., Tomás, M., Marco-Hernández, A. V., Orellana, C., Martínez, F., Roselló, M., Caro, A., Oltra Soler, J. S., Monfort, S., Sánchez, A., Rausell, D., …, & Santos-Ocaña, C. (2024). New variants expand the neurological phenotype of COQ7 deficiency. Journal of Inherited Metabolic Disease. https://doi.org/10.1002/jimd.12776
Vancouver
Fabra MA, Paredes-Fuentes AJ, Torralba Carnerero M, Moreno Férnandez de Ayala DJ, Arroyo Luque A, Sánchez Cuesta A, et al. New variants expand the neurological phenotype of COQ7 deficiency. Journal of Inherited Metabolic Disease. 2024. doi:10.1002/jimd.12776
BibTeX
@article{Fabra2024,
author = {Fabra, María Alcázar and Paredes-Fuentes, Abraham J and Torralba Carnerero, Manuel and Moreno Férnandez de Ayala, Daniel J and Arroyo Luque, Antonio and Sánchez Cuesta, Ana and Staiano, Carmine and Sanchez-Pintos, Paula and Luz Couce, María and Tomás, Miguel and Marco-Hernández, Ana Victoria and Orellana, Carmen and Martínez, Francisco and Roselló, Mónica and Caro, Alfonso and Oltra Soler, Juan Silvestre and Monfort, Sandra and Sánchez, Alejandro and Rausell, Dolores and Vitoria, Isidro and Del Toro, Mireia and Garcia-Cazorla, Angels and Julia-Palacios, Natalia A and Jou, Cristina and Yubero, Delia and López, Luis Carlos and Hernández Camacho, Juan Diego and López Lluch, Guillermo and Ballesteros Simarro, Manuel and Rodríguez Aguilera, Juan Carlos and Calvo, Gloria Brea and Cascajo Almenara, María Victoria and Artuch, Rafael and Santos-Ocaña, Carlos},
title = {New variants expand the neurological phenotype of COQ7 deficiency},
journal = {Journal of Inherited Metabolic Disease},
year = {2024},
doi = {10.1002/jimd.12776}
}
EUVIMED